Beijing Chunlizhengda Medical Instruments Co Ltd (688236) — Net Asset Quality Index
Beijing Chunlizhengda Medical Instruments Co Ltd (688236) has a Net Asset Quality Index of 84.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.54 Billion minus total liabilities of CN¥554.08 Million yields net assets of CN¥2.99 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Beijing Chunlizhengda Medical Instrument (688236) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Beijing Chunlizhengda Medical Instruments Co Ltd Net Asset Quality Index Over Time (2012–2024)
This chart shows how Beijing Chunlizhengda Medical Instruments Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 84.3%, representing net assets of CN¥2.99 Billion against total assets of CN¥3.54 Billion CNY. For live market cap and overall valuation, see Beijing Chunlizhengda Medical Instrument (688236) market capitalisation.
Annual Net Asset Quality Index for Beijing Chunlizhengda Medical Instruments Co Ltd (2012–2024)
The table below presents the year-by-year Net Asset Quality Index for Beijing Chunlizhengda Medical Instruments Co Ltd from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Beijing Chunlizhengda Medical Instrument book value and equity for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 81.4% | CN¥2.82 Billion | CN¥3.47 Billion | CN¥644.39 Million | ▲ +2.5 pp |
| 2023 | 78.9% | CN¥2.88 Billion | CN¥3.65 Billion | CN¥770.33 Million | ▼ -0.9 pp |
| 2022 | 79.8% | CN¥2.72 Billion | CN¥3.41 Billion | CN¥690.07 Million | ▼ -2.5 pp |
| 2021 | 82.3% | CN¥2.47 Billion | CN¥3.00 Billion | CN¥530.58 Million | ▲ +12.2 pp |
| 2020 | 70.1% | CN¥1.08 Billion | CN¥1.54 Billion | CN¥460.41 Million | ▲ +3.4 pp |
| 2019 | 66.7% | CN¥806.59 Million | CN¥1.21 Billion | CN¥402.72 Million | ▼ -10.4 pp |
| 2018 | 77.1% | CN¥628.14 Million | CN¥814.74 Million | CN¥186.60 Million | ▼ -7.9 pp |
| 2017 | 85.0% | CN¥538.47 Million | CN¥633.66 Million | CN¥95.19 Million | ▼ -4.1 pp |
| 2016 | 89.0% | CN¥480.91 Million | CN¥540.13 Million | CN¥59.22 Million | ▲ +0.4 pp |
| 2015 | 88.6% | CN¥423.56 Million | CN¥478.04 Million | CN¥54.49 Million | ▲ +2.8 pp |
| 2014 | 85.9% | CN¥205.92 Million | CN¥239.86 Million | CN¥33.94 Million | ▼ -3.8 pp |
| 2013 | 89.7% | CN¥179.89 Million | CN¥200.63 Million | CN¥20.74 Million | ▼ -2.7 pp |
| 2012 | 92.4% | CN¥173.17 Million | CN¥187.51 Million | CN¥14.34 Million | — |